Annual ROE
87.60%
+786.65%+112.53%
31 December 2023
Summary:
Rigel Pharmaceuticals annual return on equity is currently 87.60%, with the most recent change of +786.65% (+112.53%) on 31 December 2023. During the last 3 years, it has risen by +155.32% (+229.36%). RIGL annual ROE is now at all-time high.RIGL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-14.80%
-61.44%-131.73%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly return on equity is currently -14.80%, with the most recent change of -61.44% (-131.73%) on 30 September 2024. Over the past year, it has dropped by -114.68% (-114.82%). RIGL quarterly ROE is now -105.09% below its all-time high of 291.05%, reached on 31 March 2023.RIGL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +112.5% | -114.8% |
| 3 y3 years | +229.4% | +42.7% |
| 5 y5 years | +230.8% | +71.0% |
RIGL ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +112.5% | -105.1% | +100.0% |
| 5 y | 5 years | at high | +112.5% | -105.1% | +100.0% |
| alltime | all time | at high | +105.4% | -105.1% | +100.0% |
Rigel Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -14.80%(-131.7%) |
| June 2024 | - | 46.64%(-29.2%) |
| Mar 2024 | - | 65.86%(-26.0%) |
| Dec 2023 | 87.60%(-112.5%) | 88.94%(-11.0%) |
| Sept 2023 | - | 99.88%(-43.3%) |
| June 2023 | - | 176.05%(-39.5%) |
| Mar 2023 | - | 291.05%(-100.0%) |
| Dec 2022 | -699.05%(+1156.6%) | -650.81 K%(>+9900.0%) |
| Sept 2022 | - | -652.25%(+133.5%) |
| June 2022 | - | -279.39%(+53.6%) |
| Mar 2022 | - | -181.91%(+429.0%) |
| Dec 2021 | -55.63%(-17.9%) | -34.39%(+33.2%) |
| Sept 2021 | - | -25.81%(+96.7%) |
| June 2021 | - | -13.12%(-30.3%) |
| Mar 2021 | - | -18.83%(-64.5%) |
| Dec 2020 | -67.72%(-17.1%) | -53.02%(+20.7%) |
| Sept 2020 | - | -43.93%(+20.3%) |
| June 2020 | - | -36.51%(-2.4%) |
| Mar 2020 | - | -37.42%(-54.6%) |
| Dec 2019 | -81.73%(+22.1%) | -82.34%(+61.6%) |
| Sept 2019 | - | -50.96%(-11.4%) |
| June 2019 | - | -57.53%(-7.5%) |
| Mar 2019 | - | -62.20%(-8.7%) |
| Dec 2018 | -66.96%(-33.2%) | -68.11%(-36.6%) |
| Sept 2018 | - | -107.38%(-1.3%) |
| June 2018 | - | -108.74%(-2.5%) |
| Mar 2018 | - | -111.53%(+4.5%) |
| Dec 2017 | -100.20%(+6.0%) | -106.68%(+4.2%) |
| Sept 2017 | - | -102.34%(-1.9%) |
| June 2017 | - | -104.31%(+10.2%) |
| Mar 2017 | - | -94.67%(-1.1%) |
| Dec 2016 | -94.55%(+101.8%) | -95.73%(+16.3%) |
| Sept 2016 | - | -82.29%(+43.2%) |
| June 2016 | - | -57.47%(+8.0%) |
| Mar 2016 | - | -53.23%(+9.5%) |
| Dec 2015 | -46.86%(-13.3%) | -48.61%(-6.9%) |
| Sept 2015 | - | -52.20%(-9.3%) |
| June 2015 | - | -57.57%(-1.7%) |
| Mar 2015 | - | -58.54%(+7.8%) |
| Dec 2014 | -54.03%(+50.9%) | -54.28%(+18.4%) |
| Sept 2014 | - | -45.84%(+6.9%) |
| June 2014 | - | -42.87%(+13.0%) |
| Mar 2014 | - | -37.93%(+4.9%) |
| Dec 2013 | -35.80%(-4.9%) | -36.16%(-11.3%) |
| Sept 2013 | - | -40.76%(-3.9%) |
| June 2013 | - | -42.42%(-4.3%) |
| Mar 2013 | - | -44.34%(-0.2%) |
| Dec 2012 | -37.64% | -44.43%(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | -45.85%(+18.0%) |
| June 2012 | - | -38.86%(-0.4%) |
| Mar 2012 | - | -39.01%(-1.8%) |
| Dec 2011 | -42.74%(-255.6%) | -39.72%(-0.4%) |
| Sept 2011 | - | -39.89%(+608.5%) |
| June 2011 | - | -5.63%(-118.3%) |
| Mar 2011 | - | 30.69%(+1.0%) |
| Dec 2010 | 27.46%(-126.3%) | 30.38%(+10.3%) |
| Sept 2010 | - | 27.55%(-159.6%) |
| June 2010 | - | -46.22%(-59.0%) |
| Mar 2010 | - | -112.63%(-4.5%) |
| Dec 2009 | -104.23%(-26.6%) | -117.95%(-2.8%) |
| Sept 2009 | - | -121.34%(-2.5%) |
| June 2009 | - | -124.48%(+22.4%) |
| Mar 2009 | - | -101.71%(+2.8%) |
| Dec 2008 | -142.04%(+62.0%) | -98.93%(+10.5%) |
| Sept 2008 | - | -89.51%(+15.2%) |
| June 2008 | - | -77.70%(+1.1%) |
| Mar 2008 | - | -76.89%(-7.5%) |
| Dec 2007 | -87.68%(+128.1%) | -83.11%(+9.1%) |
| Sept 2007 | - | -76.20%(+14.6%) |
| June 2007 | - | -66.48%(+34.7%) |
| Mar 2007 | - | -49.35%(+32.3%) |
| Dec 2006 | -38.44%(-31.7%) | -37.31%(+25.1%) |
| Sept 2006 | - | -29.82%(-16.6%) |
| June 2006 | - | -35.77%(-33.6%) |
| Mar 2006 | - | -53.85%(-18.2%) |
| Dec 2005 | -56.26%(-53.9%) | -65.83%(-23.7%) |
| Sept 2005 | - | -86.27%(-15.6%) |
| June 2005 | - | -102.26%(+19.6%) |
| Mar 2005 | - | -85.52%(-4.8%) |
| Dec 2004 | -121.93%(-3.2%) | -89.86%(+4.8%) |
| Sept 2004 | - | -85.71%(+7.4%) |
| June 2004 | - | -79.81%(-15.2%) |
| Mar 2004 | - | -94.07%(-15.1%) |
| Dec 2003 | -125.96%(-7.5%) | -110.81%(+5.8%) |
| Sept 2003 | - | -104.76%(-2.1%) |
| June 2003 | - | -107.06%(+0.0%) |
| Mar 2003 | - | -107.02%(+5.1%) |
| Dec 2002 | -136.18%(+123.0%) | -101.85%(+10.7%) |
| Sept 2002 | - | -91.97%(+17.2%) |
| June 2002 | - | -78.46%(+12.5%) |
| Mar 2002 | - | -69.77%(+15.8%) |
| Dec 2001 | -61.08%(-40.1%) | -60.24%(+8.2%) |
| Sept 2001 | - | -55.65%(+4.8%) |
| June 2001 | - | -53.09%(+8.4%) |
| Mar 2001 | - | -48.98%(-5.3%) |
| Dec 2000 | -101.92%(-93.8%) | -51.74% |
| Dec 1999 | -1635.71% | - |
FAQ
- What is Rigel Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual ROE year-on-year change?
- What is Rigel Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly ROE year-on-year change?
What is Rigel Pharmaceuticals annual return on equity?
The current annual ROE of RIGL is 87.60%
What is the all time high annual ROE for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual return on equity is 87.60%
What is Rigel Pharmaceuticals annual ROE year-on-year change?
Over the past year, RIGL annual return on equity has changed by +786.65% (+112.53%)
What is Rigel Pharmaceuticals quarterly return on equity?
The current quarterly ROE of RIGL is -14.80%
What is the all time high quarterly ROE for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly return on equity is 291.05%
What is Rigel Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, RIGL quarterly return on equity has changed by -114.68% (-114.82%)